CytoMed Therapeutics Limited Cash Flows From Used In Financing Activities
CytoMed Therapeutics Limited (GDTC) reported Cash Flows From Used In Financing Activities of SGD 208.65 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2026-03-31
SGD
| Period end | Cash Flows From Used In Financing Activities 12 month |
|---|---|
| 2025-12-31 | 208.65K SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | -64.89K SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 10.92M SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | 968.72K SGD 20-F · filed 2025-04-28 |
| 2021-12-31 | 4.17M SGD 20-F · filed 2024-04-22 |
| 2020-12-31 | 1.88M SGD 20-F · filed 2023-05-01 |
USD
| Period end | Cash Flows From Used In Financing Activities 12 month |
|---|---|
| 2025-12-31 | $162.26K 20-F · filed 2026-03-31 |
| 2024-12-31 | -$47.50K 20-F · filed 2025-04-28 |
| 2023-12-31 | $8.28M 20-F · filed 2024-04-22 |
| 2022-12-31 | $722.71K 20-F · filed 2023-05-01 |